Travere Therapeutics (TVTX)

• Market cap: $2.74B
• 1 day: 1.26%
• 5 days: 2.31%
• 1 month: -10.26%
• 3 months: -16.1%
• 6 months: 75.76%
• Year to date: -22.57%
• 1 year: 31.9%
• 5 years: 16%
• 10 years: 118.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Employees: 385